Acquisition announcements are rarely short of confidence.
Management talks about combining complementary businesses, unlocking efficiencies, expanding into new markets and creating substantial shareholder value. Cost savings are quantified. Revenue opportunities are described. Integration plans sound achievable.
Then the acquisition completes.
Two years later, the original promises can be surprisingly difficult to find.
The goodwill remains on the balance sheet. Management may describe the acquisition as strategically important. The annual report may discuss integration progress in broad terms.
What investors often struggle to see is whether the benefits used to justify the original purchase price were actually delivered.
That is one reason acquisition disclosures and goodwill remain under scrutiny. The IASB is continuing to consider proposals that would give investors more information about significant acquisitions, including expected synergies and subsequent performance.
For boards, this creates a simple challenge.
If a synergy number was important enough to justify paying for an acquisition, management should be able to explain where the number came from, how it will be achieved and whether it eventually happened.
For ACCA SBR candidates, this is a strong current reporting issue because it brings together IFRS 3, goodwill, impairment, professional judgement, investor information and corporate governance.
Candidates working with an ACCA SBR tutor should be able to move beyond simply defining goodwill and explain how acquisition promises connect with the numbers reported several years later.
What exactly is a synergy?
A synergy is a benefit expected from combining businesses that would not be available to them separately, or would be harder to achieve independently.
Cost synergies are usually easier to understand.
Two companies may have overlapping offices, duplicated finance teams, separate IT systems or different supplier contracts. Combining the businesses may allow management to remove duplication and reduce costs.
Revenue synergies are often less certain.
The acquirer may expect to sell its products to the target’s customers, enter new markets, increase prices, improve customer retention or combine distribution networks.
There may also be operational synergies.
The combined group might improve manufacturing efficiency, use excess capacity, share technology or reduce logistics costs.
These expected benefits can explain why an acquirer is willing to pay more than the fair value of the identifiable net assets purchased.
That excess may ultimately contribute to goodwill.
The difficulty is that an expected synergy is not the same as a delivered synergy.
Acquisition models make the future look very tidy
Before an acquisition is approved, management normally prepares detailed forecasts.
Those models often show a convincing sequence.
Revenue increases.
Costs fall.
Integration completes on schedule.
Customers stay.
Key employees remain.
Systems combine successfully.
The acquisition produces a return comfortably above the company’s required rate.
The spreadsheet may be internally consistent. That does not mean the assumptions are realistic.
Acquisition models are prepared when management is trying to decide whether to buy a business. There may also be pressure to justify a transaction that senior executives already support.
Optimism can enter the model easily.
Revenue opportunities may be overstated because management assumes that customers will respond positively to the combined offering.
Cost savings may be recognised too quickly.
Integration costs may be understated.
The risk of losing employees, customers or suppliers may receive less attention than the potential benefits.
This does not mean acquisition forecasts are deliberately misleading.
It means they require challenge.
Boards should ask where every major synergy comes from
A figure such as “£20 million of annual synergies” sounds impressive.
It is also meaningless without an explanation.
The board should understand what creates the £20 million.
A useful synergy analysis should identify:
- whether the benefit comes from additional revenue or lower costs
- which part of the business is expected to generate it
- when the benefit should begin
- what expenditure is required to achieve it
- who is responsible for delivery
- how actual performance will be measured
- what assumptions could prevent the benefit being achieved
This is the only bullet list needed because the underlying principle is straightforward.
A synergy should be capable of being traced from the acquisition case into operational plans and eventually into actual performance.
If nobody can explain the number six months after the deal, it probably was not robust enough before the deal.
Cost synergies are not automatically easy money
Cost savings often appear more reliable than revenue synergies because management can identify a specific expense that might disappear.
Two businesses may not need two head offices.
One finance system may replace two.
Supplier contracts may be renegotiated.
Duplicated management positions may be removed.
However, the gross saving is not the same as the net economic benefit.
Closing an office may involve lease exit costs.
Removing employees creates redundancy costs.
Replacing an IT system requires implementation expenditure.
Combining operations may temporarily reduce productivity.
Suppliers may not agree to the expected pricing improvements.
A company claiming £10 million of annual cost synergies may need to spend £15 million before those savings begin.
That does not make the acquisition unattractive. It means investors need enough information to understand the complete picture.
Boards should therefore challenge both the amount and the cost of delivery.
Revenue synergies deserve even more scepticism
Revenue synergies are usually harder to prove.
Management may believe that the acquired company’s customers will buy products from the wider group.
That is possible.
It is not guaranteed.
Customers may already use another supplier. The products may not fit their needs. Competitors may respond by reducing prices. The acquisition itself may damage customer relationships.
The same uncertainty applies to geographic expansion.
Buying an established company in another country may provide access to a market, but access does not automatically produce profitable growth.
Local regulation, customer preferences, pricing structures and competition may be different from management’s expectations.
Revenue synergies should therefore be supported by commercial evidence.
Has management tested customer demand?
Are sales teams actually able to cross-sell the products?
Are there contractual restrictions?
Does the target customer base overlap with the acquirer’s existing market?
What investment is needed before new revenue can be generated?
A board that accepts a revenue synergy because it sounds strategically attractive may be approving value that never appears.
Synergies need owners
One of the simplest acquisition controls is also one of the most useful.
Every major synergy should have an owner.
If the acquisition case assumes procurement savings, someone should be responsible for delivering them.
If the model assumes higher sales through cross-selling, someone should own that sales programme.
If management expects savings from consolidating systems, responsibility should sit with a named executive and a defined implementation plan.
Without ownership, synergy numbers can remain trapped inside the acquisition model.
They become assumptions that supported the purchase price but never become operational targets.
The finance team should then track actual performance against those targets.
This creates a direct link between the investment decision and subsequent accountability.
The original acquisition case should not disappear after completion
A common governance weakness is that the acquisition model receives intense scrutiny before approval and very little attention afterwards.
Once the deal completes, reporting moves onto integration updates and normal monthly performance.
The original assumptions fade into the background.
That makes it difficult to answer an obvious question.
Did the acquisition deliver what management said it would deliver?
Boards should preserve the original investment case and continue comparing it with actual results.
That does not mean management should be judged unfairly when circumstances change.
An unexpected recession may reduce demand.
New regulation may increase costs.
Interest rates may rise.
A competitor may introduce disruptive technology.
These events may make the original forecast impossible to achieve.
The important point is that the difference should be explained.
Investors need to distinguish between a good acquisition affected by unexpected events and an acquisition built on unrealistic assumptions from the beginning.
Underperformance needs an explanation rather than a new story
When acquisitions miss their original targets, management may naturally change the way success is described.
The original transaction may have been justified using revenue growth and cost savings.
Two years later, the discussion may focus on strategic positioning, market access or long-term potential.
Those benefits may be genuine.
However, they should not quietly replace the original objectives simply because the numbers were missed.
Boards should maintain consistency.
If the acquisition was approved because management expected £15 million of annual cost savings, subsequent reporting should explain whether those savings occurred.
If they did not, the company should explain why.
If the acquisition was expected to deliver significant cross-selling opportunities, management should explain the actual outcome.
Changing the measure of success after the event weakens accountability.
This is where better acquisition disclosures become valuable
The current IASB work on Business Combinations – Disclosures, Goodwill and Impairment is intended to improve the information investors receive about acquisitions.
The proposals have included greater information about the objectives and subsequent performance of strategically important business combinations and quantitative information about expected synergies.
The precise requirements remain under development and are not yet final.
That distinction matters for SBR candidates.
A current-issues answer should not present proposals as existing IFRS requirements.
The stronger approach is to explain the reporting problem and the direction of the proposed solution.
Investors often receive detailed information when an acquisition is announced but less information about whether the expected benefits were subsequently delivered.
Improved disclosures could help close that gap.
Quantifying expected synergies creates discipline
Requiring companies to quantify significant expected synergies could improve acquisition reporting for a simple reason.
Numbers force specificity.
It is easy to say that combining two businesses will create substantial efficiencies.
It is harder to state that procurement savings are expected to reach £6 million annually within three years.
Once management gives a number and a timeframe, investors can understand the scale of the expected benefit.
Boards can also monitor it.
This may improve discipline before the acquisition is approved.
Management knows that ambitious synergy assumptions may eventually need to be explained publicly.
That creates an incentive to make them realistic and supportable.
There is also a commercial sensitivity problem
Companies do have legitimate concerns about disclosing detailed acquisition information.
A competitor could potentially learn useful information from expected cost savings, pricing plans or integration strategies.
Customers might react to planned changes.
Employees could become concerned if cost synergies clearly imply redundancies.
A company negotiating with suppliers might not want to reveal the savings it expects to achieve.
This creates a genuine tension.
Investors want enough information to evaluate whether management paid a sensible price and whether the transaction delivered.
Management wants to avoid disclosing commercially sensitive information that could damage the combined business.
Good reporting has to balance those interests.
That is why any disclosure framework needs appropriate safeguards while still preventing companies from using commercial sensitivity as a blanket reason to provide vague information.
Synergy reporting links directly to goodwill
Expected synergies matter because they help explain why goodwill arises.
Suppose a company pays £500 million for a business whose identifiable net assets have a fair value of £350 million.
Part of the remaining amount may reflect expected benefits from combining the businesses.
If those benefits never arrive, investors may reasonably question whether the goodwill remains supportable.
However, the connection is not always immediate.
Goodwill is not normally tested as a standalone asset.
It is allocated to cash-generating units or groups of units expected to benefit from the acquisition.
This can make acquisition performance difficult to see.
Strong existing operations can hide a weak acquisition
One criticism of goodwill impairment testing is the possibility of shielding.
Imagine an established division already generates strong cash flows.
Management acquires another company and allocates goodwill to a cash-generating unit that includes both the existing operations and the acquired business.
The acquisition then performs poorly.
However, the original business continues to perform strongly.
Those existing cash flows may provide enough headroom to support the combined carrying amount.
No impairment is recognised.
That does not necessarily mean the accounting is wrong under current requirements.
It does mean investors may struggle to see that the acquisition itself failed to deliver.
Better subsequent performance disclosures can therefore provide information that the impairment test alone may not reveal quickly.
A failed synergy does not automatically mean goodwill is impaired
Candidates need to be careful here.
If a particular synergy is not achieved, goodwill does not automatically need to be written off.
The impairment test compares the carrying amount of the relevant cash-generating unit with its recoverable amount.
The unit may still generate sufficient value.
Other benefits may have emerged.
Market conditions may have changed.
The acquisition may still be commercially successful despite missing one original target.
The correct SBR response is therefore not:
“The synergy failed, so goodwill must be impaired.”
The stronger response is:
“The failure to achieve expected synergies is evidence that management’s original assumptions should be reassessed and may indicate an impairment risk.”
That leads naturally into a review of forecast cash flows, growth assumptions, margins and discount rates.
Forecasts used for impairment should reflect what actually happened
This is where boards need strong professional scepticism.
Suppose an acquisition was expected to create £10 million of annual savings.
After two years, only £2 million has been achieved.
Management’s impairment model still assumes that the remaining £8 million will appear over the following year.
That might be possible.
It needs evidence.
The board should ask why delivery was delayed and what has changed to make the revised forecast credible.
Repeatedly pushing benefits into future years can keep an optimistic valuation alive long after the original business case has weakened.
A robust impairment process should compare previous forecasts with actual results.
Management’s forecasting history matters.
If forecasts have consistently overstated growth or understated integration costs, that should influence the level of scepticism applied to the latest assumptions.
Acquisition reporting should connect across the annual report
The acquisition story should be consistent.
If the strategic report says integration is ahead of plan, the numbers should provide support.
If management celebrates substantial synergy delivery, the related margins or costs should show some evidence of improvement.
If the goodwill impairment test has very little headroom, highly confident acquisition commentary may require further explanation.
The same applies to investor presentations.
A business should not describe an acquisition as transformative when talking to investors and then provide only generic boilerplate information in the financial statements.
Connected reporting makes management accountable for the same story throughout the organisation.
What audit committees should challenge
Audit committees have an important role because acquisition accounting contains significant judgement.
They should challenge the original assumptions and continue challenging them after completion.
Questions should include whether synergy estimates remain consistent with actual performance, whether integration costs have been fully reflected, whether goodwill is allocated appropriately and whether impairment forecasts rely on benefits that management has repeatedly failed to deliver.
The audit committee should also understand how acquisition performance is monitored internally.
If senior management no longer measures the acquisition using the indicators presented when the deal was approved, the committee should ask why.
Sometimes a change in measurement is justified.
Sometimes it makes underperformance less visible.
How this could appear in an SBR exam
An SBR scenario could describe a company that acquired a competitor two years ago.
Management originally expected significant purchasing savings and increased revenue through cross-selling.
The cost savings have been delayed.
Revenue growth has been lower than forecast.
The finance director nevertheless argues that no impairment review is needed because the overall division remains profitable.
That scenario contains several issues.
A weak answer would define goodwill and explain the annual impairment test.
A stronger answer would recognise that failure to achieve the original synergies may indicate that the assumptions supporting the acquisition should be reconsidered.
The candidate could challenge the cash flow forecast, compare previous predictions with actual performance and explain the risk of shielding if goodwill has been allocated to a large cash-generating unit.
The answer could also discuss whether investors receive enough information about the acquisition’s subsequent performance.
That is where technical knowledge becomes professional advice.
Avoid turning the answer into a deal-making essay
Synergy is a commercial concept, but an SBR answer still needs a reporting focus.
You are not being asked whether mergers and acquisitions are generally good or bad.
Connect the synergy discussion to:
acquisition disclosures, goodwill, cash-generating units, impairment indicators, cash flow forecasts, professional scepticism and investor information.
Then make a recommendation.
For example:
“Management should compare the acquisition’s actual performance with the original synergy assumptions and reassess the cash flow forecasts used in the impairment test. The audit committee should challenge any benefits that have repeatedly been delayed and ensure that material underperformance is explained clearly to investors.”
That is concise, applied and board-ready.
Why this topic matters beyond the exam
The debate around acquisition disclosures is ultimately about accountability.
Management decides to spend shareholders’ money buying another business.
The board approves the transaction.
Expected synergies often form an important part of the justification.
Investors should then be able to understand whether those expectations were reasonable and whether they were delivered.
That does not mean every forecast must be achieved.
Business is uncertain.
It does mean that the original promises should remain visible.
If a company expected £20 million of savings and delivered £5 million, investors should not have to reconstruct that information from several years of annual reports.
What candidates should take from the current debate
For current SBR candidates, the most useful lesson is not to memorise every detail of the IASB project.
Understand the reporting problem.
Acquisition announcements can provide detailed information about expected benefits.
Subsequent financial statements may provide much less information about whether those benefits occurred.
Goodwill impairment alone may not give investors a timely picture of acquisition performance.
Better disclosures could improve accountability, while also creating questions about commercial sensitivity and implementation cost.
That gives you a balanced current-issues discussion.
Candidates using an ACCA SBR course should practise applying that discussion to a scenario rather than reproducing it as a general essay.
The numbers eventually need to mean something
Synergies are easy to describe before an acquisition.
The difficult part comes afterwards.
Did costs actually fall?
Did customers buy more?
Was integration completed?
Were the forecast benefits achieved within the promised timeframe?
Did the purchase price still make sense?
Those questions matter to boards, investors and auditors.
They also explain why acquisition reporting is moving towards greater accountability for the promises made when deals are approved.
A synergy number should not disappear once the acquisition completes.
If it helped justify the price, someone should eventually have to prove it.